NCT03977077

Treatment of Advanced Gastrointestinal Tumors With Albumin Taxol

A Retrospective Clinical Study on the Efficacy and Safety of Injection Taxol (Albumin Binding Type) in the Treatment of Patients With Advanced Gastrointestinal Tumors

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Henan Cancer Hospital · Other Government
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to evaluate the safety and efficacy of domestic injection paclitaxel (albumin binding type) in patients with advanced digestive tract tumors,and to further explore the possible predictors of efficacy.In order to provide more effective chemotherapeutic drugs, prolong survival time and improve quality of life for patients with advanced digestive tract tumors.

Conditions

• Advanced Gastrointestinal Tumors

Interventions

Type	Name	Description
DRUG	Albumin binding taxol	125mg/m2, d1, 8, intravenous infusion for 30min, 1 cycle every 3 weeks;Other combined chemotherapy drugs and drug doses shall be administered by clinicians according to the guidelines and the actual situation of clinical patients.

Timeline

• Start date: 2019-06-01
• Primary completion: 2019-10-31
• Completion: 2020-10-31
• First posted: 2019-06-06
• Last updated: 2019-06-06

Locations

1 site across 1 country: China